Series A · Medtech & Devices · Vienna, Austria · Founded 2022 · 11–50 employees
Vienna-based Flinn develops AI-driven software that automates critical regulatory and quality compliance processes for medical device and pharmaceutical manufacturers. The company's platform centralizes data to streamline workflows such as post-market surveillance, literature evaluation, and complaint handling under complex MDR and IVDR regulations. In February 2026, the startup secured a twenty million dollar Series A funding round led by HV Capital. This significant capital injection follows a prior six million euro seed round raised in late 2024. Flinn plans to leverage this investment to expand its team from approximately forty employees up to eighty by the end of 2026.
No open roles listed right now.